Wells Fargo Maintains Equal-Weight on Health Catalyst, Raises Price Target to $1.75
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
Wells Fargo analyst Stan Berenshteyn maintains Health Catalyst (NASDAQ:HCAT) with a Equal-Weight and raises the price target from $1 to $1.75.
Wells Fargo analyst Stan Berenshteyn maintains Health Catalyst (NASDAQ:HCAT) with a Equal-Weight and raises the price target from $1 to $1.75.